Topics and Expertise: biotechnology industry

A UC San Francisco-created, insulin-generating implant that utilizes nanotechnology is closer to becoming a real treatment for diabetes, after being acquired by a San Francisco-based startup.

James Wells, PhD, whose pioneering innovations in protein engineering and technologies to identify small molecules to aid in drug discovery have yielded more than 60 patents, launched three companies, and created two UCSF technology centers, has been elected as a fellow to the National Academy of...

A new collaboration between Celgene Corp. and the Recombinant Antibody Network (RAN) will support the development of next-generation, antibody-based cancer therapies. The RAN is a consortium comprising researchers from the UCSF School of Pharmacy (UCSF Antibiome Center), the University of Chicago,...

Charles S. Craik, PhD, whose innovative research has generated ten patents and helped launch two companies, has been named a fellow by the National Academy of Inventors (NAI).